Loading company…
ID 404999604 · FY 2023–2024 · 2 years
Subsidiary of შეზღუდული პასუხისმგებლობის საზოგადოება ისთჰორნ ქლინიქალ სერვისიზ ინ სიიი ლიმითიდი (100.0%)
კომპანიის ძირითად საქმიანობას წარმოადგენს სამედიცინო კვლევების წარმოება საქართველოში.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| Net Cash from Operating Activities | 11 | 336 | +3071.3% |
| Net Cash used in Investing Activities | -147 | -155 | +5.7% |
| Free Cash Flow (OCF − Capex proxy) | -136 | 181 | nmf |
| Net Cash from Financing Activities | -1 | -1 | +123.1% |
| Net Change in Cash (before FX) | -136 | 180 | nmf |
| Effect of FX on Cash | -2 | -47 | +2393.1% |
| Net Change in Cash (incl. FX) | -138 | 133 | nmf |
| Cash at Beginning of Year | 168 | 29 | -82.5% |
| Cash at End of Year | 29 | 162 | +453.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Ownership & directors from companyinfo.ge (public corporate registry).